Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer.

作者: Anna Sivula , Anne Talvensaari-Mattila , Johan Lundin , Heikki Joensuu , Caj Haglund

DOI: 10.1007/S10549-004-0714-4

关键词: Gene expressionBreast cancerCarcinogenesisCancer researchMetastasisProteolytic enzymesMatrix metalloproteinaseCancerPathologyBiologyImmunohistochemistry

摘要: Expression of cyclooxygenase-2 (COX-2) and matrix metalloproteinase-2 (MMP-2) associates with reduced survival in human breast cancer. COX-2 may be directly involved mammary carcinogenesis, since expression is sufficient for formation tumors transgenic mice, selective inhibitors can suppress tumorigenesis rodent models MMP-2 an extracellular degrading proteolytic enzyme that bas been linked to invasion metastasis. A direct link between exist, inhibition activity result reduction activity. In this study we analyzed protein tissue array specimens 278 invasive cancers by immunohistochemistry. Immunopositivity these two markers was correlated each other various clinicopathological parameters including survival. We found high 30% 83% the cancer specimens, there a positive association factors (p=0.003). It especially evident whenever high, almost invariably (95%). Furthermore, either or associated decreased disease specific when compared MPP-2 low group (p=0.026 p=0.021, respectively). Taken together, our results indicate both are poor prognosis

参考文章(33)
Phillip J. Daschner, Joseph A. Tangrea, Barbara H. Kasprzak, Grace C. Yeh, Philip R. Taylor, Duminda Ratnasinghe, Miriam R. Anver, Cyclooxygenase-2, P-glycoprotein-170 and drug resistance; is chemoprevention against multidrug resistance possible? Anticancer Research. ,vol. 21, pp. 2141- 2147 ,(2001)
Namita Kundu, Amy M Fulton, Selective Cyclooxygenase (COX)-1 or COX-2 Inhibitors Control Metastatic Disease in a Murine Model of Breast Cancer Cancer Research. ,vol. 62, pp. 2343- 2346 ,(2002)
Kotha Subbaramaiah, Kotha Subbaramaiah, Howard T. Thaler, Baoheng Du, Louise R. Howe, Anthony M. C. Brown, Jaime L. Masferrer, Clifford Hudis, William J. Muller, Andrew J. Dannenberg, Jay Patel, Aparna Deora, Celecoxib, a selective cyclooxygenase 2 inhibitor, protects against human epidermal growth factor receptor 2 (HER-2)/neu-induced breast cancer. Cancer Research. ,vol. 62, pp. 5405- 5407 ,(2002)
Steven R. Patierno, Fadwa A. Attiga, Michael J. Manyak, Patricia M. Fernandez, Ashani T. Weeraratna, Inhibitors of prostaglandin synthesis inhibit human prostate tumor cell invasiveness and reduce the release of matrix metalloproteinases. Cancer Research. ,vol. 60, pp. 4629- 4637 ,(2000)
Yoshitaka Takahashi, Futoshi Kawahara, Masakuni Noguchi, Koichi Miwa, Hiroshi Sato, Motoharu Seiki, Hiroyasu Inoue, Tadashi Tanabe, Tanihiro Yoshimoto, Activation of matrix metalloproteinase-2 in human breast cancer cells overexpressing cyclooxygenase-1 or -2 FEBS Letters. ,vol. 460, pp. 145- 148 ,(1999) , 10.1016/S0014-5793(99)01328-9
E M Connolly, J H Harmey, T O'Grady, D Foley, G Roche-Nagle, E Kay, D J Bouchier-Hayes, Cyclo-oxygenase inhibition reduces tumour growth and metastasis in an orthotopic model of breast cancer British Journal of Cancer. ,vol. 87, pp. 231- 237 ,(2002) , 10.1038/SJ.BJC.6600462
M Parrett, R Harris, F Joarder, M Ross, K Clausen, F Robertson, Cyclooxygenase-2 gene expression in human breast cancer. International Journal of Oncology. ,vol. 10, pp. 503- 507 ,(1997) , 10.3892/IJO.10.3.503
L. A. Liotta, K. Tryggvason, S. Garbisa, Ian Hart, C. M. Foltz, S. Shafie, Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature. ,vol. 284, pp. 67- 68 ,(1980) , 10.1038/284067A0
W. D. CROTCH, Letters to Editors Nature. ,vol. 2, pp. 67- 67 ,(1870) , 10.1038/002067B0
Mikala Egeblad, Zena Werb, New functions for the matrix metalloproteinases in cancer progression Nature Reviews Cancer. ,vol. 2, pp. 161- 174 ,(2002) , 10.1038/NRC745